Albert David Ltd vs Brawn Biotech Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 04, 2026

Key Highlights

The Latest Trading Price of Albert David Ltd is ₹ 723.75 as of 04 May 11:12 . The P/E Ratio of Albert David Ltd changed from 9.7 on March 2021 to 26.9 on March 2025 . This represents a CAGR of 22.63% over 5 yearsThe P/E Ratio of Brawn Biotech Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of Albert David Ltd changed from ₹ 215.12 crore on March 2021 to ₹ 463.25 crore on March 2025 . This represents a CAGR of 16.58% over 5 yearsThe Market Cap of Brawn Biotech Ltd changed from ₹ 6.63 crore on March 2021 to ₹ 4.88 crore on March 2025 . This represents a CAGR of -5.95% over 5 years The revenue of Albert David Ltd for the Dec '25 is ₹ 102.33 crore as compare to the Sep '25 revenue of ₹ 85.1 crore. This represent the growth of 20.25% The revenue of Brawn Biotech Ltd for the Dec '25 is ₹ 4.4 crore as compare to the Sep '25 revenue of ₹ 4.98 crore. This represent the decline of -11.65% The ebitda of Albert David Ltd for the Dec '25 is ₹ 23.22 crore as compare to the Sep '25 ebitda of ₹ 0.4 crore. This represent the growth of 5705% The ebitda of Brawn Biotech Ltd for the Dec '25 is ₹ 0.08 crore as compare to the Sep '25 ebitda of ₹ 0.1 crore. This represent the decline of -20% The net profit of Albert David Ltd changed from ₹ 18.84 crore to ₹ 15.3 crore over 7 quarters. This represents a CAGR of -11.21% The net profit of Brawn Biotech Ltd changed from ₹ -0.53 crore to ₹ 0.05 crore over 7 quarters. This represents a CAGR of NaN% The Dividend Payout of Albert David Ltd changed from 15.47 % on March 2021 to 16.6 % on March 2025 . This represents a CAGR of 1.42% over 5 yearsThe Dividend Payout of Brawn Biotech Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Albert David Ltd

Albert David Limited (ADL), a Unit of Kothari Group, was incorporated in 1938 at Calcutta.
The Company belongs to a renowned industrial house of Kolkata, the 'Kothari Group'.
The Company's principal business is manufacturing and trading of Pharmaceutical Formulations, Infusion Solutions, Herbal Dosage Forms and Bulk Drugs by way of domestic sale or export.
Apart from these, it manufactures disposable syringes and needles and a wide range of bulk drugs.
It is recognised as a large IV fluid manufacturer, both in glass and polyethylene containers. ADL has entered into a technical collaboration with Morishita Pharmaceuticals, Japan, a subsidiary of Ajinomoto -- the world leader in amino acids -- to manufacture amino acid infusions, for which it came out with a rights issue in Aug.'87.

About Brawn Biotech Ltd

Brawn Biotech Limited was originally incorporated in the name of Brawn Pharmaceuticals Limited in November, 1985.
Thereafter, the name of the Company was changed from Brawn Pharmaceuticals Limited to Brawn Biotech Limited in November, 2010.
Brawn, with its inception barely 38 years back has today evolved into a fully integrated, healthcare group, marking its presence in India and across the globe. The Company possess product registration with major health and govt. institutions throughout India and worldwide.
Headed and represented by a team of skilled industry experts with impressive educational backgrounds and broad experience, the Company has spread its wings in expansion in the domestic as well as in the international markets beyond the existing horizon to stand among the leading Indian HealthCare products distribution Companies.

FAQs for the comparison of Albert David Ltd and Brawn Biotech Ltd

Which company has a larger market capitalization, Albert David Ltd or Brawn Biotech Ltd?

Market cap of Albert David Ltd is 411 Cr while Market cap of Brawn Biotech Ltd is 5 Cr

What are the key factors driving the stock performance of Albert David Ltd and Brawn Biotech Ltd?

The stock performance of Albert David Ltd and Brawn Biotech Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Albert David Ltd and Brawn Biotech Ltd?

As of May 4, 2026, the Albert David Ltd stock price is INR ₹720.05. On the other hand, Brawn Biotech Ltd stock price is INR ₹19.0.

How do dividend payouts of Albert David Ltd and Brawn Biotech Ltd compare?

To compare the dividend payouts of Albert David Ltd and Brawn Biotech Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.